(VIANEWS) - Yesterday, the Innrs artificial intelligence algorithm suggested a few financial assets that would make investors a profit today.
Via News is daily fact-checking an AI algorithm that aims to predict financial assets' next session's price and next week's trend.
Innrs provides AI-based statistical tools to help investors make decisions.
If you had invested in last session's Innrs AI prediction, you would have a ROI of -0.18%.
| Financial Asset | Accuracy | Previous Close | Prediction | Close Price | ROI |
|---|---|---|---|---|---|
| American Airlines (AAL) | 88.5% | $14.5 | $14.04 | $13.83 | 4.62% ✅ |
| Southwestern Energy (SWN) | 87.87% | $7.16 | $7.1 | $6.84 | 4.47% ✅ |
| Generac Holdlings (GNRC) | 87.25% | $105.25 | $103.14 | $102.06 | 3.03% ✅ |
| Ulta Beauty (ULTA) | 93.94% | $448.35 | $449.37 | $457.24 | 1.98% ✅ |
| Interactive Brokers Group (IBKR) | 93.59% | $77.69 | $79.83 | $78.51 | 1.06% ✅ |
| Merck (MRK) | 94.14% | $107.5 | $110.58 | $108.45 | 0.88% ✅ |
| Fifth Third Bancorp (FITBI) | 89.58% | $25.5 | $25.61 | $25.58 | 0.31% ✅ |
| Astrazeneca (AZN) | 89.16% | $66.17 | $67.13 | $66.21 | 0.06% ✅ |
| Johnson & Johnson (JNJ) | 88.67% | $177.24 | $180.86 | $177.33 | 0.05% ✅ |
| Bristol (BMY) | 93.42% | $79.24 | $81.54 | $79.14 | -0.13% |
| Sempra Energy (SRE) | 88.65% | $163.46 | $167.29 | $163.08 | -0.23% |
| Royalty Pharma (RPRX) | 88.67% | $42.98 | $43.31 | $42.87 | -0.26% |
| Dropbox (DBX) | 93.76% | $22.28 | $22.67 | $22.21 | -0.31% |
| Horizon Therapeutics (HZNP) | 88.13% | $78.28 | $79.89 | $78 | -0.36% |
| Chubb Corporation (CB) | 89.26% | $216.23 | $219.7 | $215.4 | -0.38% |
| Cardinal Health (CAH) | 89.25% | $78.95 | $79.75 | $78.46 | -0.62% |
| Etsy (ETSY) | 88.24% | $120.31 | $124.16 | $119.48 | -0.69% |
| AbbVie (ABBV) | 89.4% | $159.62 | $162.33 | $158.43 | -0.75% |
| Starbucks (SBUX) | 87.57% | $99.56 | $102.36 | $98.66 | -0.9% |
| Tractor Supply Company (TSCO) | 94.27% | $224.02 | $228.9 | $221.88 | -0.96% |
| Consolidated Edison (ED) | 93.73% | $97.5 | $99.12 | $96.54 | -0.98% |
| Rogers Communication (RCI) | 88.95% | $45.59 | $46.34 | $45.14 | -0.99% |
| Darden Restaurants (DRI) | 89.11% | $148.39 | $151.67 | $146.82 | -1.06% |
| Zebra Technologies (ZBRA) | 87.39% | $271.9 | $281.74 | $269 | -1.07% |
| Gilead Sciences (GILD) | 93.4% | $86.26 | $87.92 | $85.21 | -1.22% |
| TJX Companies (TJX) | 88.84% | $81.03 | $82.35 | $80.03 | -1.23% |
| Nasdaq Inc (NDAQ) | 89.11% | $67.15 | $68.33 | $66.27 | -1.31% |
| Zoetis (ZTS) | 89.32% | $150.1 | $151.71 | $148.13 | -1.31% |
| Broadridge Financial Solutions (BR) | 89.13% | $148.52 | $151.95 | $146.5 | -1.36% |
| The Travelers Companies (TRV) | 93.08% | $188.91 | $193.53 | $186.32 | -1.37% |
| Super Micro Computer (SMCI) | 87.64% | $93.87 | $94.66 | $92.5 | -1.46% |
| NewMarket (NEU) | 88.42% | $317.77 | $325.67 | $312.68 | -1.6% |
| Bank of New York Mellon (BK) | 87.92% | $45.67 | $47 | $44.8 | -1.9% |
1. American Airlines (AAL)
Shares of American Airlines slid 2.45% in from $14.2 to $13.85 at 21:29 EST on Monday, following the last session's downward trend. NASDAQ is falling 1.58% to $11,049.50, after two successive sessions in a row of losses.
American Airlines Group Inc., through its subsidiaries, operates as a network air carrier.
Earnings Per Share
As for profitability, American Airlines has a trailing twelve months EPS of $-14.73.
Yearly Top and Bottom Value
American Airlines's stock is valued at $13.85 at 21:29 EST, way under its 52-week high of $21.42 and way above its 52-week low of $11.65.
Moving Average
American Airlines's worth is above its 50-day moving average of $13.51 and below its 200-day moving average of $15.26.Volatility
American Airlines's last week, last month's, and last quarter's current intraday variation average was a negative 0.38%, a negative 0.06%, and a positive 2.35%.
American Airlines's highest amplitude of average volatility was 2.85% (last week), 1.94% (last month), and 2.35% (last quarter).
More news about American Airlines.
2. Southwestern Energy (SWN)
Shares of Southwestern Energy slid 1.76% in from $6.93 to $6.81 at 21:29 EST on Monday, after four consecutive sessions in a row of losses. NYSE is falling 1.51% to $15,370.44, following the last session's downward trend.
Southwestern Energy Company, an independent energy company, engages in the exploration, development, and production of natural gas, oil, and natural gas liquids (NGLs) in the United States.
Earnings Per Share
As for profitability, Southwestern Energy has a trailing twelve months EPS of $-2.44.
The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is negative -194.73%.More news about Southwestern Energy.
3. Generac Holdlings (GNRC)
Shares of Generac Holdlings dropped by a staggering 13.42% in from $118.09 to $102.24 at 21:29 EST on Monday, after four successive sessions in a row of losses. NYSE is sliding 1.51% to $15,370.44, following the last session's downward trend.
Generac Holdings Inc. designs, manufactures, and sells power generation equipment, energy storage systems, and other power products for the residential, and light commercial and industrial markets worldwide.
Earnings Per Share
As for profitability, Generac Holdlings has a trailing twelve months EPS of $7.12.
PE Ratio
Generac Holdlings has a trailing twelve months price to earnings ratio of 14.35. Meaning, the purchaser of the share is investing $14.35 for every dollar of annual earnings.
The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 26.39%.Moving Average
Generac Holdlings's worth is way below its 50-day moving average of $170.39 and way below its 200-day moving average of $238.95.More news about Generac Holdlings.
4. Ulta Beauty (ULTA)
Shares of Ulta Beauty rose 8.92% in from $419.1 to $456.48 at 21:29 EST on Monday, after two successive sessions in a row of gains. NASDAQ is dropping 1.58% to $11,049.50, after two sequential sessions in a row of losses.
Ulta Beauty, Inc. operates as a retailer of beauty products in the United States.
Earnings Per Share
As for profitability, Ulta Beauty has a trailing twelve months EPS of $3.11.
PE Ratio
Ulta Beauty has a trailing twelve months price to earnings ratio of 146.78. Meaning, the purchaser of the share is investing $146.78 for every dollar of annual earnings.
The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 62.03%.Sales Growth
Ulta Beauty's sales growth for the next quarter is 6.6%.
Yearly Top and Bottom Value
Ulta Beauty's stock is valued at $456.48 at 21:29 EST, above its 52-week high of $451.30.
More news about Ulta Beauty.
5. Interactive Brokers Group (IBKR)
Shares of Interactive Brokers Group fell 2.09% in from $80.2 to $78.52 at 21:29 EST on Monday, following the last session's upward trend. NASDAQ is sliding 1.58% to $11,049.50, after two sequential sessions in a row of losses.
Interactive Brokers Group, Inc. operates as an automated electronic broker worldwide.
Earnings Per Share
As for profitability, Interactive Brokers Group has a trailing twelve months EPS of $3.4.
PE Ratio
Interactive Brokers Group has a trailing twelve months price to earnings ratio of 23.11. Meaning, the purchaser of the share is investing $23.11 for every dollar of annual earnings.
The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 14.8%.Growth Estimates Quarters
The company's growth estimates for the ongoing quarter and the next is 42.2% and 51.2%, respectively.Dividend Yield
As maintained by Morningstar, Inc., the next dividend payment is on Nov 29, 2022, the estimated forward annual dividend rate is 0.4 and the estimated forward annual dividend yield is 0.51%.
Sales Growth
Interactive Brokers Group's sales growth is 36% for the present quarter and 43.3% for the next.
More news about Interactive Brokers Group.
6. Merck (MRK)
Shares of Merck jumped 7.02% in from $101.25 to $108.36 at 21:29 EST on Monday, after two successive sessions in a row of gains. NYSE is falling 1.51% to $15,370.44, following the last session's downward trend.
Merck & Co., Inc. operates as a healthcare company worldwide.
Earnings Per Share
As for profitability, Merck has a trailing twelve months EPS of $2.77.
PE Ratio
Merck has a trailing twelve months price to earnings ratio of 39.13. Meaning, the purchaser of the share is investing $39.13 for every dollar of annual earnings.
The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 43.42%.More news about Merck.
7. Fifth Third Bancorp (FITBI)
Shares of Fifth Third Bancorp jumped 1.19% in from $25.26 to $25.56 at 21:29 EST on Monday, following the last session's upward trend. NASDAQ is falling 1.58% to $11,049.50, after two sequential sessions in a row of losses.
Fifth Third is a bank that's as long on innovation as it is on history.
Earnings Per Share
As for profitability, Fifth Third Bancorp has a trailing twelve months EPS of $2.72.
PE Ratio
Fifth Third Bancorp has a trailing twelve months price to earnings ratio of 9.39. Meaning, the purchaser of the share is investing $9.39 for every dollar of annual earnings.
The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 12.08%.Dividend Yield
As stated by Morningstar, Inc., the next dividend payment is on Sep 26, 2022, the estimated forward annual dividend rate is 1.66 and the estimated forward annual dividend yield is 6.54%.
Volatility
Fifth Third Bancorp's last week, last month's, and last quarter's current intraday variation average was 0.05%, 0.11%, and 0.69%.
Fifth Third Bancorp's highest amplitude of average volatility was 0.39% (last week), 0.78% (last month), and 0.69% (last quarter).
More news about Fifth Third Bancorp.
8. Astrazeneca (AZN)
Shares of Astrazeneca rose by a staggering 12.57% in from $58.79 to $66.18 at 21:29 EST on Monday, after five successive sessions in a row of gains. NYSE is dropping 1.51% to $15,370.44, following the last session's downward trend.
AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines.
Earnings Per Share
As for profitability, Astrazeneca has a trailing twelve months EPS of $1.52.
PE Ratio
Astrazeneca has a trailing twelve months price to earnings ratio of 43.67. Meaning, the purchaser of the share is investing $43.67 for every dollar of annual earnings.
The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is negative -4.84%.Dividend Yield
As claimed by Morningstar, Inc., the next dividend payment is on Aug 10, 2022, the estimated forward annual dividend rate is 1.45 and the estimated forward annual dividend yield is 2.52%.
Yearly Top and Bottom Value
Astrazeneca's stock is valued at $66.18 at 21:29 EST, below its 52-week high of $71.70 and way above its 52-week low of $52.65.
Volatility
Astrazeneca's last week, last month's, and last quarter's current intraday variation average was 0.11%, 0.61%, and 1.33%.
Astrazeneca's highest amplitude of average volatility was 0.11% (last week), 1.08% (last month), and 1.33% (last quarter).
Stock Price Classification
According to the stochastic oscillator, a useful indicator of overbought and oversold conditions,Astrazeneca's stock is considered to be oversold (<=20).
More news about Astrazeneca.
9. Johnson & Johnson (JNJ)
Shares of Johnson & Johnson jumped 1.86% in from $174.1 to $177.34 at 21:29 EST on Monday, after four successive sessions in a row of gains. NYSE is dropping 1.51% to $15,370.44, following the last session's downward trend.
Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide.
Earnings Per Share
As for profitability, Johnson & Johnson has a trailing twelve months EPS of $5.66.
PE Ratio
Johnson & Johnson has a trailing twelve months price to earnings ratio of 31.33. Meaning, the purchaser of the share is investing $31.33 for every dollar of annual earnings.
Dividend Yield
According to Morningstar, Inc., the next dividend payment is on Nov 20, 2022, the estimated forward annual dividend rate is 4.52 and the estimated forward annual dividend yield is 2.62%.
Sales Growth
Johnson & Johnson's sales growth is negative 3.6% for the present quarter and 0.7% for the next.
Moving Average
Johnson & Johnson's worth is higher than its 50-day moving average of $167.84 and above its 200-day moving average of $172.18.Stock Price Classification
According to the stochastic oscillator, a useful indicator of overbought and oversold conditions,Johnson & Johnson's stock is considered to be oversold (<=20).
More news about Johnson & Johnson.
10. Bristol (BMY)
Shares of Bristol jumped 1.92% in from $77.51 to $79.00 at 21:29 EST on Monday, after two sequential sessions in a row of losses. NYSE is falling 1.51% to $15,370.44, following the last session's downward trend.
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide.
Earnings Per Share
As for profitability, Bristol has a trailing twelve months EPS of $-2.76.
The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 19.09%.Growth Estimates Quarters
The company's growth estimates for the current quarter and the next is a negative 7.5% and a negative 3.8%, respectively.Stock Price Classification
According to the stochastic oscillator, a useful indicator of overbought and oversold conditions,Bristol's stock is considered to be oversold (<=20).
Dividend Yield
As stated by Morningstar, Inc., the next dividend payment is on Jun 29, 2022, the estimated forward annual dividend rate is 2.16 and the estimated forward annual dividend yield is 2.93%.
Sales Growth
Bristol's sales growth is negative 3.4% for the ongoing quarter and negative 4.6% for the next.
More news about Bristol.
11. Sempra Energy (SRE)
Shares of Sempra Energy jumped 7.52% in from $151.13 to $162.49 at 21:29 EST on Monday, after two consecutive sessions in a row of losses. NYSE is dropping 1.51% to $15,370.44, following the last session's downward trend.
Sempra operates as an energy-services holding company in the United States and internationally.
Earnings Per Share
As for profitability, Sempra Energy has a trailing twelve months EPS of $12.88.
PE Ratio
Sempra Energy has a trailing twelve months price to earnings ratio of 12.62. Meaning, the purchaser of the share is investing $12.62 for every dollar of annual earnings.
The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 5.1%.Volume
Today's last reported volume for Sempra Energy is 539021 which is 60.01% below its average volume of 1348170.
Yearly Top and Bottom Value
Sempra Energy's stock is valued at $162.49 at 21:29 EST, below its 52-week high of $176.47 and way higher than its 52-week low of $119.56.
More news about Sempra Energy.
12. Royalty Pharma (RPRX)
Shares of Royalty Pharma rose 1.37% in from $42.31 to $42.89 at 21:29 EST on Monday, following the last session's downward trend. NASDAQ is sliding 1.58% to $11,049.50, after two consecutive sessions in a row of losses.
Royalty Pharma plc operates as a buyer of biopharmaceutical royalties and a funder of innovations in the biopharmaceutical industry in the United States.
Earnings Per Share
As for profitability, Royalty Pharma has a trailing twelve months EPS of $1.93.
PE Ratio
Royalty Pharma has a trailing twelve months price to earnings ratio of 22.27. Meaning, the purchaser of the share is investing $22.27 for every dollar of annual earnings.
The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 8.6%.Dividend Yield
As maintained by Morningstar, Inc., the next dividend payment is on Nov 16, 2022, the estimated forward annual dividend rate is 0.76 and the estimated forward annual dividend yield is 1.83%.
Revenue Growth
Year-on-year quarterly revenue growth declined by 3.4%, now sitting on 2.26B for the twelve trailing months.
More news about Royalty Pharma.
13. Dropbox (DBX)
Shares of Dropbox jumped 1.93% in from $21.74 to $22.16 at 21:29 EST on Monday, after two consecutive sessions in a row of losses. NASDAQ is dropping 1.58% to $11,049.50, after two successive sessions in a row of losses.
Dropbox, Inc. provides a content collaboration platform worldwide.
Earnings per Share
Dropbox's trailing 12 month EPS is $-0.62.
Sales Growth
Dropbox sales growth was 5% in the most recent quarter, and 5% the following.
More news about Dropbox.
14. Horizon Therapeutics (HZNP)
Shares of Horizon Therapeutics rose by a staggering 24.98% in from $62.42 to $78.01 at 21:29 EST on Monday, following the last session's downward trend. NASDAQ is falling 1.58% to $11,049.50, after two successive sessions in a row of losses.
Horizon Therapeutics Public Limited Company is a biotechnology firm that focuses on developing and marketing medicines to address the critical medical needs of people with rare and severe inflammatory conditions.
Earnings per Share
Horizon Therapeutics' trailing twelve-month EPS is $1.81.
PE Ratio
Horizon Therapeutics' trailing 12 months earnings to price ratio is 43.1. The purchaser of the shares is therefore investing $43.1 per dollar in annual earnings.
For the 12 trailing months, the company's return-on-equity, which is a measure of the profitability and shareholder equity for a business, was 16.96%.Volatility
Horizon Therapeutics's last week, last month's, and last quarter's current intraday variation average was 0.32%, 0.90%, and 1.83%.
Horizon Therapeutics's highest amplitude of average volatility was 0.56% (last week), 2.04% (last month), and 1.83% (last quarter).
Sales Growth
Horizon Therapeutics's sales growth is negative 9.3% for the present quarter and negative 9.6% for the next.
Revenue growth
The year-on-year revenue growth was 5.3%. It now stands at 3.81B in the 12 trailing months.
Yearly Top and Bottom Value
Horizon Therapeutics's stock is valued at $78.01 at 21:30 EST, way below its 52-week high of $117.49 and way above its 52-week low of $57.84.
More news about Horizon Therapeutics.
15. Chubb Corporation (CB)
Shares of Chubb Corporation slid 0.07% in from $215.23 to $215.08 at 21:29 EST on Monday, following the last session's downward trend. NYSE is dropping 1.51% to $15,370.44, following the last session's downward trend.
Chubb Limited provides insurance and reinsurance products worldwide.
Earnings Per Share
As for profitability, Chubb Corporation has a trailing twelve months EPS of $12.32.
PE Ratio
Chubb Corporation has a trailing twelve months price to earnings ratio of 17.46. Meaning, the purchaser of the share is investing $17.46 for every dollar of annual earnings.
The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 11.48%.Moving Average
Chubb Corporation's value is higher than its 50-day moving average of $196.45 and above its 200-day moving average of $200.16.Volatility
Chubb Corporation's last week, last month's, and last quarter's current intraday variation average was a positive 0.37%, a negative 0.04%, and a positive 1.27%.
Chubb Corporation's highest amplitude of average volatility was 0.63% (last week), 0.74% (last month), and 1.27% (last quarter).
More news about Chubb Corporation.
16. Cardinal Health (CAH)
Shares of Cardinal Health rose 2.98% in from $76.07 to $78.34 at 21:29 EST on Monday, following the last session's downward trend. NYSE is sliding 1.51% to $15,370.44, following the last session's downward trend.
Cardinal Health, Inc. is an integrated health services and products provider in America, Canada, Europe, Asia, Europe, Asia, as well as internationally.
Earnings per Share
Cardinal Health's trailing 12 months profit per share (EPS) is $4.7
PE Ratio
Cardinal Health's trailing 12 months earnings to price ratio is 16.65. The purchaser of the shares is therefore investing $16.65 per dollar in annual earnings.
For the 12 trailing months, the company's return-on-equity, which is a measure of the profitability of a company relative to shareholders' equity, was negative at -171.32%.Revenue Growth
Year-on-year quarterly revenue growth grew by 10.6%, now sitting on 181.36B for the twelve trailing months.
Annual Top and Bottom Value
At 21:30 EST, Cardinal Health's stock was valued at $78.34. This is below its 52 week high of $81.57 but well above its 52 week low of $45.85.
Volume
Cardinal Health's current reported volume is 1930870, which is 38.13% lower than its average volume (32120870).
Dividend Yield
Morningstar, Inc. estimates that the next dividend payment will be made on September 29, 2022. The forward annual dividend rate for the future is estimated at 1.98, and the forward annual dividend yield to be 2.65%.
More news about Cardinal Health.
17. Etsy (ETSY)
Shares of Etsy rose by a staggering 26.85% in from $94.12 to $119.39 at 21:29 EST on Monday, following the last session's downward trend. NASDAQ is sliding 1.58% to $11,049.50, after two consecutive sessions in a row of losses.
Etsy, Inc. runs two-sided online marketplaces which connect sellers and buyers primarily in the United States, Canada, Australia, France, Germany, Australia, France, Germany, Australia, France, India, Australia, Canada, Australia, France, Germany, Australia, France, Germany, Australia, France, France, Germany, Australia, France, India, and the United Kingdom.
Earnings Per Share
As for profitability, Etsy has a trailing twelve months EPS of $2.69.
PE Ratio
Etsy has a trailing twelve months price to earnings ratio of 44.37. Meaning, the purchaser of the share is investing $44.37 for every dollar of annual earnings.
The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 73.87%.Volume
The Etsy last reported Volume is now 2091000, which is 36.05% lower than its Average Volume of 3270050.
Sales Growth
Etsy's sales growth for the next quarter is 3.6%.
Volatility
Etsy's intraday variation average for the week and quarter ended last week was 0.06%. Its month-end and quarter end results were 1.09% and 3.21%, respectively.
Etsy had the highest average volatility amplitude: 0.52% last week, 4.16% last month and 3.21% in the quarter.
More news about Etsy.
18. AbbVie (ABBV)
Shares of AbbVie jumped 8.26% in from $146.2 to $158.28 at 21:29 EST on Monday, following the last session's downward trend. NYSE is falling 1.51% to $15,370.44, following the last session's downward trend.
AbbVie Inc. develops, manufactures and markets pharmaceuticals worldwide.
Earnings Per Share
As for profitability, AbbVie has a trailing twelve months EPS of $2.91.
PE Ratio
AbbVie has a trailing twelve months price to earnings ratio of 54.34. Meaning, the purchaser of the share is investing $54.34 for every dollar of annual earnings.
The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 92.71%.Revenue growth
The year-on-year revenue growth was 4.5%. We now have 57.35 billion for the 12 trailing months.
More news about AbbVie.
19. Starbucks (SBUX)
Shares of Starbucks rose by a staggering 14.19% in from $86.57 to $98.85 at 21:29 EST on Monday, following the last session's downward trend. NASDAQ is dropping 1.58% to $11,049.50, after two successive sessions in a row of losses.
Starbucks Corporation, together with its subsidiaries, operates as a roaster, marketer, and retailer of specialty coffee worldwide.
Earnings per Share
Starbucks' trailing 12 month EPS is $0.85.
PE Ratio
Starbucks' trailing 12-month price-earnings ratio is 116.44. The purchaser of the shares is likely to invest $116.44 per dollar in annual earnings.
Volatility
Starbucks's last week, last month's, and last quarter's current intraday variation average was 0.08%, 0.65%, and 1.69%.
Starbucks's highest amplitude of average volatility was 0.69% (last week), 1.46% (last month), and 1.69% (last quarter).
More news about Starbucks.
20. Tractor Supply Company (TSCO)
Shares of Tractor Supply Company jumped 1.26% in from $219.73 to $222.50 at 21:29 EST on Monday, after two sequential sessions in a row of losses. NASDAQ is sliding 1.58% to $11,049.50, after two sequential sessions in a row of losses.
Tractor Supply Company is a retailer of rural lifestyle products in the United States.
Earnings per Share
Tractor Supply Company's trailing 12 months EPS is $7.22.
PE Ratio
Tractor Supply Company's trailing 12 months earnings to price ratio is 30.82. The purchaser of the shares is investing $30.82 per dollar in annual earnings.
For the 12 trailing months, the company's return-on-equity, which is a measure of the business' profitability relative to shareholders' equity, was 52.46%.Yearly Top and Bottom Value
Tractor Supply Company's stock is valued at $222.50 at 21:33 EST, below its 52-week high of $241.54 and way higher than its 52-week low of $166.49.
More news about Tractor Supply Company.
21. Consolidated Edison (ED)
Shares of Consolidated Edison rose 9.43% in from $88.03 to $96.33 at 21:29 EST on Monday, after two successive sessions in a row of losses. NYSE is sliding 1.51% to $15,370.44, following the last session's downward trend.
Consolidated Edison, Inc., through its subsidiaries, engages in the regulated electric, gas, and steam delivery businesses in the United States.
Earnings per Share
Consolidated Edison's trailing 12-month EPS is $3.28.
PE Ratio
Consolidated Edison's trailing 12-month price-to-earnings ratio is 29.37. The purchaser of the shares is therefore investing $29.37 per dollar in annual earnings.
For the 12 trailing months, the company's return-on-equity, which is a measure of the profitability and shareholder equity for a business, was 6.65%.Dividend Yield
According to Morningstar, Inc., the next dividend payment is on Aug 15, 2022, the estimated forward annual dividend rate is 3.16 and the estimated forward annual dividend yield is 3.18%.
Stock Price Classification
According to the stochastic oscillator, a useful indicator of overbought and oversold conditions,Consolidated Edison's stock is considered to be oversold (<=20).
Growth Estimates Quarters
The company's growth estimates for the ongoing quarter and the next is 11.3% and 6.4%, respectively.Revenue growth
The year-over-year revenue growth was 10.4%. It now stands at 14.06B in the 12 trailing months.
More news about Consolidated Edison.
22. Rogers Communication (RCI)
Shares of Rogers Communication jumped 8.35% in from $41.66 to $45.14 at 21:29 EST on Monday, after two successive sessions in a row of losses. NYSE is falling 1.51% to $15,370.44, following the last session's downward trend.
Rogers Communications Inc. is a Canadian communications and media company.
Earnings per Share
Rogers Communication's trailing twelve-month EPS is $2.57.
PE Ratio
Rogers Communication's trailing 12 months earnings to price ratio is 17.54. The purchaser of the shares is therefore investing $17.54 per dollar in annual earnings.
For the 12 trailing months, the company's return-on-equity, which is a measure of the profitability and shareholder equity for a company, was 16.22%.Annual Top and Bottom Value
Rogers Communication stock was valued at $45.14 as of 21:33 EST. This is way lower than its 52 week high of $64.55 but higher than its 52 week low of $36.23.
Dividend Yield
Morningstar, Inc. estimates that the next dividend payment will be made on September 7, 2022. The forward dividend rate for the year is estimated at 1.55, and the forward dividend yield to be 3.38%.
Revenue Growth
Year-on-year quarterly revenue growth grew by 8%, now sitting on 15.07B for the twelve trailing months.
Sales Growth
Rogers Communication's sales growth is 2% for the present quarter and 1.8% for the next.
More news about Rogers Communication.
23. Darden Restaurants (DRI)
Shares of Darden Restaurants rose 2.58% in from $143.24 to $146.94 at 21:29 EST on Monday, following the last session's downward trend. NYSE is falling 1.51% to $15,370.44, following the last session's downward trend.
Darden Restaurants, Inc., through its subsidiaries, owns and operates full-service restaurants in the United States and Canada.
Earnings per Share
Darden Restaurants' trailing 12 months profit per share was $-1.7
For the 12 trailing months, the company's return-on-equity, which is a measure of the profitability and shareholder equity for a business, was 38.06%.Volume
Darden Restaurants' last reported volume is now 628997, 48.62% lower than its usual volume (1224350).
Revenue Growth
Year-on-year quarterly revenue growth grew by 6.1%, now sitting on 9.77B for the twelve trailing months.
Stock Price Classification
According to the stochastic oscillator, a useful indicator of overbought and oversold conditions,Darden Restaurants's stock is considered to be oversold (<=20).
More news about Darden Restaurants.
24. Zebra Technologies (ZBRA)
Shares of Zebra Technologies dropped 5.82% in from $285.16 to $268.56 at 21:29 EST on Monday, following the last session's downward trend. NASDAQ is sliding 1.58% to $11,049.50, after two consecutive sessions in a row of losses.
Zebra Technologies Corporation, together with its subsidiaries, provides enterprise asset intelligence solutions in the automatic identification and data capture solutions industry worldwide.
Earnings Per Share
As for profitability, Zebra Technologies has a trailing twelve months EPS of $9.35.
PE Ratio
Zebra Technologies has a trailing twelve months price to earnings ratio of 28.72. Meaning, the purchaser of the share is investing $28.72 for every dollar of annual earnings.
The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 19.48%.More news about Zebra Technologies.
25. Gilead Sciences (GILD)
Shares of Gilead Sciences rose 8.62% in from $78.44 to $85.20 at 21:29 EST on Monday, following the last session's downward trend. NASDAQ is sliding 1.58% to $11,049.50, after two successive sessions in a row of losses.
Gilead Sciences, Inc., is a biopharmaceutical firm that discovers, develops, commercializes and markets medicines in areas where there are unmet medical needs in the United States, Europe, or internationally.
Earnings per Share
For profitability, Gilead Sciences' trailing twelve-month EPS is $0.24
PE Ratio
Gilead Sciences' trailing 12-month price-earnings ratio is 355. The purchaser of the shares is therefore investing $355 per dollar in annual earnings.
For the 12 trailing months, the company's return-on-equity, which is a measure of the profitability and shareholder equity for a business, was 20.58%.Stock Price Classification
According to the stochastic oscillator, a useful indicator of overbought and oversold conditions,Gilead Sciences's stock is considered to be overbought (>=80).
More news about Gilead Sciences.
26. TJX Companies (TJX)
Shares of TJX Companies jumped by a staggering 10.95% in from $72.07 to $79.96 at 21:29 EST on Monday, after two consecutive sessions in a row of losses. NYSE is dropping 1.51% to $15,370.44, following the last session's downward trend.
The TJX Companies, Inc., together with its subsidiaries, operates as an off-price apparel and home fashions retailer.
Earnings Per Share
As for profitability, TJX Companies has a trailing twelve months EPS of $0.07.
PE Ratio
TJX Companies has a trailing twelve months price to earnings ratio of 1142.36. Meaning, the purchaser of the share is investing $1142.36 for every dollar of annual earnings.
The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 56.86%.Moving Average
TJX Companies's value is way higher than its 50-day moving average of $65.52 and way higher than its 200-day moving average of $63.33.Yearly Top and Bottom Value
TJX Companies's stock is valued at $79.96 at 21:34 EST, above its 52-week high of $77.35.
Dividend Yield
Morningstar, Inc. has stated that the next dividend payment will be on Aug 9, 2022. The forward dividend rate for the year is estimated at 1.18, and the forward dividend yield to be 1.93%.
More news about TJX Companies.
27. Nasdaq Inc (NDAQ)
Shares of Nasdaq Inc jumped 6.48% in from $62.22 to $66.25 at 21:29 EST on Monday, following the last session's downward trend. NASDAQ is sliding 1.58% to $11,049.50, after two successive sessions in a row of losses.
Nasdaq, Inc. operates as a technology company that serves capital markets and other industries worldwide.
Earnings Per Share
As for profitability, Nasdaq Inc has a trailing twelve months EPS of $6.15.
PE Ratio
Nasdaq Inc has a trailing twelve months price to earnings ratio of 10.77. Meaning, the purchaser of the share is investing $10.77 for every dollar of annual earnings.
The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 18.66%.Sales Growth
Nasdaq Inc's sales growth is 2.7% for the current quarter and 3% for the next.
Volatility
The intraday variation average for Nasdaq Inc in the last week, month, and quarter was negative 0.133%, positive 0.32% and positive 1.43%.
Nasdaq Inc had the highest average volatility amplitudes of 0.76%, 1.20% and 1.43% respectively.
Yearly Top and Bottom Value
Nasdaq Inc's stock is valued at $66.25 at 21:34 EST, under its 52-week high of $70.55 and way higher than its 52-week low of $46.77.
Dividend Yield
According to Morningstar, Inc., the next dividend payment is on Nov 30, 2022, the estimated forward annual dividend rate is 0.8 and the estimated forward annual dividend yield is 1.33%.
More news about Nasdaq Inc.
28. Zoetis (ZTS)
Shares of Zoetis dropped 1.85% in from $150.79 to $148.00 at 21:29 EST on Monday, after four successive sessions in a row of losses. NYSE is falling 1.51% to $15,370.44, following the last session's downward trend.
Zoetis Inc. discovers, develops, manufactures, and commercializes animal health medicines, vaccines, and diagnostic products in the United States and internationally.
Earnings Per Share
As for profitability, Zoetis has a trailing twelve months EPS of $3.42.
PE Ratio
Zoetis has a trailing twelve months price to earnings ratio of 43.27. Meaning, the purchaser of the share is investing $43.27 for every dollar of annual earnings.
The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 47.31%.Dividend Yield
Morningstar, Inc. estimates that the next dividend payment will be on July 19, 2022. The forward annual dividend rate for the year is estimated at 1.3, and the forward annual dividend yield to be 0.71%.
More news about Zoetis.
29. Broadridge Financial Solutions (BR)
Shares of Broadridge Financial Solutions fell 2.48% in from $149.91 to $146.19 at 21:29 EST on Monday, following the last session's downward trend. NYSE is dropping 1.51% to $15,370.44, following the last session's downward trend.
Broadridge Financial Solutions, Inc. provides investor communications and technology-driven solutions for the financial services industry.
Earnings Per Share
As for profitability, Broadridge Financial Solutions has a trailing twelve months EPS of $4.43.
PE Ratio
Broadridge Financial Solutions has a trailing twelve months price to earnings ratio of 33.04. Meaning, the purchaser of the share is investing $33.04 for every dollar of annual earnings.
The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 32.34%.More news about Broadridge Financial Solutions.
30. The Travelers Companies (TRV)
Shares of The Travelers Companies rose 0.9% in from $184.56 to $186.22 at 21:29 EST on Monday, after two successive sessions in a row of losses. NYSE is sliding 1.51% to $15,370.44, following the last session's downward trend.
The Travelers Companies, Inc., through its subsidiaries, provides a range of commercial and personal property, and casualty insurance products and services to businesses, government units, associations, and individuals in the United states and internationally.
Earnings Per Share
As for profitability, The Travelers Companies has a trailing twelve months EPS of $11.06.
PE Ratio
The Travelers Companies has a trailing twelve months price to earnings ratio of 16.83. Meaning, the purchaser of the share is investing $16.83 for every dollar of annual earnings.
The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 13.87%.More news about The Travelers Companies.
31. Super Micro Computer (SMCI)
Shares of Super Micro Computer rose by a staggering 32.48% in from $69.58 to $92.18 at 21:29 EST on Monday, following the last session's downward trend. NASDAQ is falling 1.58% to $11,049.50, after two consecutive sessions in a row of losses.
Super Micro Computer, Inc., together with its subsidiaries, develops and manufactures high-performance server and storage solutions based on modular and open architecture.
Earnings per Share
Super Micro Computer's trailing twelve-month EPS is $1.64.
PE Ratio
Super Micro Computer's trailing 12-month price-earnings ratio is 56.31. The purchaser of the shares is investing $56.31 per dollar in annual earnings.
For the 12 trailing months, the company's return-on-equity, which is a measure of the profitability and shareholder equity for a business, was 22.61%.Revenue Growth
Year-on-year quarterly revenue growth grew by 53%, now sitting on 5.2B for the twelve trailing months.
Volatility
Super Micro Computer's intraday variation average for the week and quarter ended last week at 1.81%, 1.52% and 3.25%, respectively.
Super Micro Computer had the highest average volatility amplitude at 2.79%, 3.48% and 3.25% respectively (last week, last month, and last quarter).
Volume
The Super Micro Computer's current reported volume is 812165, which is 13.7% more than its average volume (713836).
More news about Super Micro Computer.
32. NewMarket (NEU)
Shares of NewMarket jumped 2.46% in from $304.76 to $312.26 at 21:29 EST on Monday, following the last session's downward trend. NYSE is falling 1.51% to $15,370.44, following the last session's downward trend.
NewMarket Corporation, through its subsidiaries, engages in the petroleum additives business.
Earnings Per Share
As for profitability, NewMarket has a trailing twelve months EPS of $23.32.
PE Ratio
NewMarket has a trailing twelve months price to earnings ratio of 13.39. Meaning, the purchaser of the share is investing $13.39 for every dollar of annual earnings.
The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 28.64%.Revenue Growth
Year-on-year quarterly revenue growth grew by 11.9%, now sitting on 2.66B for the twelve trailing months.
Stock Price Classification
According to the stochastic oscillator, a useful indicator of overbought and oversold conditions,NewMarket's stock is considered to be oversold (<=20).
Volume
The NewMarket's latest reported volume is currently 33227, which is 21.8% lower than its average volume (42493).
Yearly Top and Bottom Value
NewMarket's stock is valued at $312.26 at 21:35 EST, way below its 52-week high of $360.77 and way above its 52-week low of $280.28.
More news about NewMarket.
33. Bank of New York Mellon (BK)
Shares of Bank of New York Mellon jumped 6.49% in from $42.08 to $44.81 at 21:29 EST on Monday, following the last session's downward trend. NYSE is sliding 1.51% to $15,370.44, following the last session's downward trend.
Bank of New York Mellon Corporation offers a variety of financial services and products in the United States as well as internationally.
Earnings per Share
Bank of New York Mellon's trailing 12-month EPS of $3.75 is a good indicator of profitability.
PE Ratio
Bank of New York Mellon's trailing 12 months earnings to price ratio is 11.95. The purchaser of the shares is therefore investing $11.95 per dollar in annual earnings.
For the 12 trailing months, the company's return-on-equity, which is a measure of the business' profitability relative to shareholders' equity, was 6.88%.More news about Bank of New York Mellon.